World's Best Scientists 2026 revealed!
Peter B. Berger

Peter B. Berger

D-Index & Metrics

Medicine

D-Index
113
Citations
56420
World Ranking
4880
National Ranking
2643

Peter B. Berger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter B. Berger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 499 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter B. Berger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter B. Berger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter B. Berger is affiliated with Duke University in the United States. Their research primarily focuses on Medicine, with particular attention to the subfields of Cardiology and Cardiovascular Medicine, Surgery, Economics and Econometrics, Oncology, and General Health Professions.

Their work covers several main research topics including Acute Myocardial Infarction Research, Cardiac, Anesthesia and Surgical Outcomes, Coronary Interventions and Diagnostics, COVID-19 and healthcare impacts, Cardiac Imaging and Diagnostics, Cardiac Arrest and Resuscitation, and Healthcare Policy and Management.

Recent publications by Peter B. Berger include the following papers:

  • Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization (2022), published in Circulation Cardiovascular Interventions
  • Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York (2020), published in The American Journal of Cardiology
  • The Association of Socioeconomic Factors With Percutaneous Coronary Intervention Outcomes (2021), published in Canadian Journal of Cardiology
  • Ad Hoc Percutaneous Coronary Intervention in Stable Patients With Multivessel or Unprotected Left Main Disease (2023), published in JACC: Cardiovascular Interventions
  • Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator (2020), published in UNC Libraries

Peter B. Berger has frequently collaborated with several co-authors across multiple publications. Notable frequent co-authors include Edward L. Hannan, Alice K. Jacobs, Frederick S. Ling, Spencer B. King, and Ferdinand J. Venditti.

The scientist's publication record shows recurring contributions to these venues:

  • The American Journal of Cardiology (3 publications)
  • UNC Libraries (3 publications)
  • Circulation Cardiovascular Interventions (1 publication)
  • Canadian Journal of Cardiology (1 publication)
  • JACC: Cardiovascular Interventions (1 publication)

In addition to journal articles, Peter B. Berger has authored a book titled Das unrettbare Ich und die Bühne (2020), published by V&R unipress eBooks.

Best Publications

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

    Steven R. Steinhubl;Peter B. Berger;J. Tift Mann;Edward T. A. Fry

  • Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

    Charanjit S. Rihal;Stephen C. Textor;Diane E. Grill;Peter B. Berger

  • Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy

    Leslee J. Shaw;Daniel S. Berman;David J. Maron;G. B. John Mancini

  • Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Jean-François Tanguay

  • Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Dominick J. Angiolillo

  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

    S. G. Chu;R. C. Becker;P. B. Berger;D. L. Bhatt

  • The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    James D. Douketis;Peter B. Berger;Andrew S. Dunn;Amir K. Jaffer

  • Variability in platelet responsiveness to clopidogrel among 544 individuals.

    Victor L. Serebruany;Steven R. Steinhubl;Peter B. Berger;Alex I. Malinin

  • Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

    Deepak L. Bhatt;Marcus D. Flather;Werner Hacke;Peter B. Berger

  • Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease

    Sotirios Tsimikas;Emmanouil S. Brilakis;Elizabeth R. Miller;Joseph P. McConnell

  • The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.

    Patricia J.M Best;Ryan Lennon;Henry H Ting;Malcolm R Bell

  • Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.

    Peter B. Berger;Stephen G. Ellis;David R. Holmes;Christopher B. Granger

  • Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

    Adnan Kastrati;Julinda Mehilli;Franz-Josef Neumann;Franz Dotzer

  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

    Roxana Mehran;Usman Baber;Philippe Gabriel Steg;Cono Ariti

  • A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

    Adnan Kastrati;Julinda Mehilli;Helmut Schühlen;Josef Dirschinger

  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

    Deepak L. Bhatt;Matthew T. Roe;Eric D. Peterson;Yun Li

  • Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.

    Gjin Ndrepepa;Peter B. Berger;Julinda Mehilli;Melchior Seyfarth

  • Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.

    Matthew J. Price;Dominick J. Angiolillo;Paul S. Teirstein;Elizabeth Lillie

  • Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

    Steven R. Steinhubl;J. David Talley;Gregory A. Braden;James E. Tcheng

Frequent Co-Authors

David R. Holmes
David R. Holmes Mayo Clinic
Eric J. Topol
Eric J. Topol Scripps Research Institute
Steven R. Steinhubl
Steven R. Steinhubl Scripps Health
Ryan J. Lennon
Ryan J. Lennon Mayo Clinic
Christopher B. Granger
Christopher B. Granger Duke University
Adnan Kastrati
Adnan Kastrati Technical University of Munich
Robert M. Califf
Robert M. Califf Duke University
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
David J. Moliterno
David J. Moliterno University of Kentucky
Emmanouil S. Brilakis
Emmanouil S. Brilakis Abbott Northwestern Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring alternative healthcare careers beyond studying Medicine in the USA, online degrees have opened up exciting and flexible options. One popular choice for quick entry into the field is registered nursing. There are cheapest online accelerated bsn programs available for students who want to become registered nurses efficiently and affordably.

If you’re already an RN, advancing your education can be more accessible with cheap rn to bsn programs designed for working professionals. For those aiming for leadership or teaching roles, pursuing one of the cheapest dnp programs can lead to even greater career opportunities.

Finally, if you don’t have a nursing background but aspire to higher-level nursing roles or advanced practice, consider direct entry nurse practitioner programs for non-nurses online. These pathways offer streamlined routes into rewarding healthcare careers, making it easier to pivot to nursing without prior experience in the field.

Best Scientists Citing Peter B. Berger

Trending Scientists

Recently Published Articles